Harvard Bioscience, Inc. (HBIO) Misses Q4 EPS by 2c

February 28, 2013 7:46 AM EST
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q4 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $28.2 million versus the consensus estimate of $29.2 million.

For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment